Coverage
-
October 25, 2019
Glancy Prongay & Murray LLP will lead the proposed class in a shareholder's suit over medication automator Omnicell's stock drop following a short-seller's critical report on the company, a California federal judge said Thursday.
1 other articles on this case.
View all »